Good Life Advisors’s Sana Biotechnology SANA Stock Holding History

Good Life Advisors’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$45.9K	Buy	+16,800	New	+$34.7K	﹤0.01%	500

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Good Life Advisors's SANA Position: Q2 2025 in Review

Good Life Advisors opened a new position in Sana Biotechnology (SANA) in Q2 2025: 16,800 shares worth $45.9K. The stake represents ﹤0.01% of the portfolio and ranks #500 among its holdings.

155 funds tracked by Wall St. Rank hold SANA as of Q2 2025.

Good Life Advisors held 16,800 shares of Sana Biotechnology worth $45.9K as of Q2 2025.
Sana Biotechnology was a new Good Life Advisors position in Q2 2025.
Sana Biotechnology made up ﹤0.01% of Good Life Advisors's portfolio in Q2 2025, its #500 holding.
155 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2025.

Based on Good Life Advisors's 13F filing for Q2 2025, filed 8 Aug 2025.